文献速递类风湿关节炎

早期类风湿关节炎缓解与低疾病活动度的功能、生活质量及结构结局比较

Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

基于ERAS和ERAN两个起始队列1986至2012年常规诊疗数据,纳入2701例早期RA患者,比较平均DAS28缓解与低疾病活动度及持续缓解状态对HAQ、SF-36和SvdH评分的影响。结果显示平均缓解者各项结局均优于低疾病活动度者,持续缓解和持续Boolean缓解也优于持续低疾病活动度,支持ACR/EULAR指南将缓解作为早期RA首选目标。

要点

  • 平均DAS28缓解者HAQ、SF-36 PCS/MCS及SvdH评分均优于低疾病活动度者。
  • 持续缓解者HAQ、SF-36 PCS/MCS及第3-5年SvdH评分优于持续低疾病活动度者。
  • 持续Boolean缓解者HAQ和SF-36 PCS/MCS评分优于持续低疾病活动度者。

核心结论

  • 常规诊疗数据支持ACR/EULAR指南,早期RA应将缓解而非低疾病活动度作为首选治疗目标。

研究设计与样本

  • 基于Early Rheumatoid Arthritis Study(ERAS)和Early Rheumatoid Arthritis Network(ERAN)起始队列1986至2012年常规诊疗数据,纳入2701例早期RA患者,采用多水平模型分析。

主要发现

  • 2701例中562例(21%)为平均缓解(mRDAS<2.6),330例(12%)为平均低疾病活动度(mLDAS 2.6-3.2),279例(10%)为持续缓解(sRDAS),203例(7.5%)为持续低疾病活动度(sLDAS),93例(3%)为持续Boolean缓解(sBR)。
  • mRDAS组较mLDAS组HAQ、SF-36 PCS、MCS及总SvdH评分改善更显著(P值0.001至<0.0001,所有时间点)。
  • sRDAS组较sLDAS组HAQ、SF-36 PCS和MCS评分更优(P值0.05至<0.0001,所有时间点),SvdH评分在第3-5年更优(P=0.05)。
  • sBR组较sLDAS组HAQ、SF-36 PCS和MCS评分更优(P值0.002至<0.0001,所有时间点)。

关键数值与推荐

  • 平均缓解定义为第1至5年平均DAS28<2.6,平均低疾病活动度定义为平均DAS28 2.6-3.2。
  • 持续缓解/低疾病活动度定义为第1年和第2年DAS28持续处于相应范围,持续Boolean缓解定义为第1年和第2年持续Boolean缓解。

临床怎么用

  • 在早期RA常规诊疗中应追求缓解而非满足于低疾病活动度,以更好改善功能、生活质量和影像学结构结局。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To examine associations between function, quality of life and structural outcomes in patients achieving remission vs low disease activity in early RA. METHODS: Demographic, clinical and radiographic variables were collected at baseline and then annually from the Early Rheumatoid Arthritis Study (ERAS) and Early Rheumatoid Arthritis Network (ERAN) inception cohorts in routine care from 1986 to 2012. Disease activity was categorized: mean DAS28 score between years 1 and 5: remission [mean remission DAS (mRDAS) <2.6] or low [mean low DAS (mLDAS) 2.6-3.2]; sustained low/remission DAS28 (sLDAS/sRDAS) at years 1 and 2; and sustained Boolean remission (sBR) at years 1 and 2. Changes in HAQ and Short Form 36 Health Survey Questionnaire [SF-36; physical (PCS) and mental (MCS) component score]) and total Sharp van der Heijde (SvdH) scores for each disease activity category were modelled using multi-level models. Covariates included year of onset, age, gender and DMARD use at first visit. RESULTS: Of 2701 patients, 562 (21%) were categorized mRDAS, 330 (12%) mLDAS, 279 (10%) sRDAS, 203 (7.5%) sLDAS and 93 (3%) sBR. Patients categorized as mRDAS had increasingly divergent improved HAQ, SF-36 PCS, MCS and total SvdH scores compared with mLDAS (P-values 0.001 to <0.0001, all time points). Patients categorized as sRDAS had better HAQ, SF-36 PCS and MCS scores (P-values 0.05 to <0.0001, all time points) and SvdH scores (P = 0.05, years 3-5) over sLDAS. sBR was associated with better HAQ, and SF-36 PCS and MCS scores over sLDAS (P-values 0.002 to <0.0001, all time points). CONCLUSION: These findings from routine care support ACR/EULAR guidelines that remission is a preferable goal over low disease activity in early RA.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Nikiphorou E, Norton SJ, Carpenter L, et al. Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network. Rheumatology (Oxford). 2020. PMID: 31580448. doi:10.1093/rheumatology/kez461

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。